-+ 0.00%
-+ 0.00%
-+ 0.00%

Zhitong Finance App News, Shisi Pharmaceutical Group (02005.HK) issued an announcement. The group has obtained approval from the China National Drug Administration for drug production registration for norepinephrine bitartrate injection (1ml: 2mg). It is a category 3 chemical drug. It is considered to have passed the consistency evaluation and is mainly used for blood pressure control in certain acute hypotensive states.

Zhitongcaijing·11/17/2026 08:41:19
Listen to the news
Zhitong Finance App News, Shisi Pharmaceutical Group (02005.HK) issued an announcement. The group has obtained approval from the China National Drug Administration for drug production registration for norepinephrine bitartrate injection (1ml: 2mg). It is a category 3 chemical drug. It is considered to have passed the consistency evaluation and is mainly used for blood pressure control in certain acute hypotensive states.